focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,166.00
Bid: 12,132.00
Ask: 12,136.00
Change: -6.00 (-0.05%)
Spread: 4.00 (0.033%)
Open: 12,180.00
High: 12,198.00
Low: 12,076.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: UK strikes continue; AstraZeneca wins Japan approvals

Wed, 28th Dec 2022 07:40

(Alliance News) - Stocks in London are set to open higher on Wednesday as UK markets returned to business following the Christmas break.

Financial markets in France, Germany, and the US had resumed trading on Tuesday.

The CAC 40 in Paris ended 0.7% higher on Tuesday, while the DAX 40 in Frankfurt rose 0.4%. Wall Street closed mixed.

The monster storm that killed dozens in the US over the Christmas weekend continued to inflict misery on New York state and air travellers nationwide Tuesday, as stories emerged of families trapped for days during the 'blizzard of the century'.

The US is considering Covid entry restrictions for travellers from China, US officials said, after Beijing dramatically loosened hardline containment measures this month.

Infections have surged across China as key pillars of its containment policy have been dismantled, prompting US officials to express concern at the potential for new variants to be unleashed.

Here is what you need to know ahead of the London market open:

----------

MARKETS

----------

FTSE 100: called up 32.49 points, or 0.4%, at 7,505.50

----------

Hang Seng: up 1.4% at 19,874.81

Nikkei 225: closed down 0.4% at 26,340.50

S&P/ASX 200: closed down 0.3% at 7,086.40

----------

DJIA: closed up 37.63 points, 0.1%, at 33,241.56

S&P 500: closed down 0.4% at 3,829.25

Nasdaq Composite: closed down 1.4% at 10,353.23

----------

EUR: higher at USD1.0652 (USD1.0641)

GBP: higher at USD1.2045 (USD1.2027)

USD: higher at JPY133.87 (JPY133.54)

Gold: lower at USD1,809.62 per ounce (USD1,812.04)

(Brent): lower at USD84.43 a barrel (USD84.89)

(changes since previous London equities close)

----------

ECONOMICS

----------

Wednesday's key economic events still to come:

10:00 EST US Richmond Fed business activity survey

16:30 EST US API weekly statistical bulletin

08:55 EST US Johnson Redbook retail sales index

10:00 EST US pending home sales index

----------

Travel disruption is expected across railways in the UK again on Wednesday, with many commuters returning to work following the Christmas break, as industrial action by rail workers continues. Members of the Transport Salaried Staffs' Association at Great Western Railway will walk out from noon to 11.59am on Thursday, and at West Midlands Trains for 24 hours from noon until the same time on Thursday. Meanwhile, unions are looking at ways to stage further strikes by splitting ballots by job titles rather than holding a single vote, according to reports. It comes after a day of travel chaos despite a rail strike by the Rail, Maritime and Transport Workers' Union coming to an end, with crowds of people left waiting at major train stations across London and many journeys delayed due to the late handover of engineering works.

----------

The Irish taoiseach has said he is "not hung up" on the introduction of a 30% tax band to help squeezed middle earners. Leo Varadkar said he is "determined" to make policy changes to ensure people can earn up to EUR50,000 a year without having to pay the highest rate of income tax. He added that whether that comes about by increasing the standard rate cut-off point or by the introduction of a middle tax rate of 30% will have to be decided at Cabinet. Varadkar proposed the introduction of a new middle rate tax band last March as a way of helping middle income earners.

----------

US President Joe Biden departed Tuesday for the US Virgin Islands, exchanging a deadly snowstorm for a Caribbean vacation – and an expected New Year's resolution to seek re-election in 2024. He took flack from early morning Fox News hosts for being "ready to go have a good time" while Americans confront the blizzard. However, Biden headed to the island of St Croix with a successful 2022 behind him and momentum building for him to declare, at the unprecedented age of 80, that he wants another four years in the White House. Whatever gets decided in the Caribbean will initially remain a closely held secret. However, Chief of Staff Ron Klain says that the announcement is only a matter of time. "The president will make that decision, I expect, shortly after the holidays," Klain said this month. "I expect the decision will be to do it."

----------

BROKER RATING CHANGES

----------

Goldman Sachs cuts Diageo price target to 4,700 (4,800) pence - 'buy'

----------

Barclays raises Drax price target to 1,100 (1,000) pence - 'overweight'

----------

COMPANIES - FTSE 100

----------

Miner Fresnillo confirmed the final testing of the downstream power distribution and control systems at the Juanicipio project in Mexico is now complete. This concludes the additional testing requesting by Mexico's state-owned power company, CFE. As a result, Fresnillo said the entire system has now been energised, and commissioning of the project has formally begun. It added that ramp up will now be conducted "at pace", with the objective of reaching full nameplate capacity in the second quarter of 2023. "Once commissioning is concluded, ore will be processed at the Juanicipio plant and could also continue to be processed at our nearby Saucito and Fresnillo operations if required," the company said.

----------

Pharmaceutical firm AstraZeneca announced the approval of a number of treatments in Japan. It said its immunotherapies Imfinxi and Imjudo have been approved in Japan for advanced liver, biliary tract and lung cancer, while its selective Bruton's tyrosine kinase inhibitor Calquence has been approved in the country for the treatment of adults with treatment-naive chronic lymphocytic leukaemia. AstraZeneca said the approvals were based on positive clinical trials.

----------

COMPANIES - FTSE 250

----------

IMI completed its acquisition of smart thermostatic control manufacturer Heatmiser UK. The acquisition was first announced at the beginning of November for an enterprise value of GBP110 million. IMI added at the time that a further GBP8 million could be paid based on Heatmiser's future financial performance. Heatmiser will become part of IMI Hydronic. Chief Executive Roy Twite said: "With Heatmiser's expertise in connected controls, we have created a significant opportunity to accelerate our growth in smart buildings."

----------

OTHER COMPANIES

----------

Impact Healthcare REIT said it has agreed to an increase in the size of its existing revolving credit facility with Clydesdale Bank, which trades as Virgin Money. The healthcare real estate investor also agreed to an extension to the term and a reduction in the margin of the facility. The revised facility has been increased to GBP50 million from GBP25 million and extends the maturity to December 2029, from March 2024. The revised facility has an improved margin of 200 basis points over the sterling overnight index average, down from 225 basis points on the original facility. This takes the group's total debt facilities to GBP241 million from GBP216 million.

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2022 Alliance News Ltd. All Rights Reserved.

More News
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.